NCT05422534RecruitingPhase 3
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Role of Mitochondrial Dysfunction in the Response to Exercise in Patients With Advance Kidney Disease
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
Frailty and sarcopenia are modifiable risk factors for morbidity and mortality in patients with ESRD. Exercise is the recommended intervention to prevent frailty and sarcopenia, however, many clinical trials have shown limited clinical improvement in muscle mass and physical function. We propose that mitochondrial dysfunction is one of the deterrents to the effectiveness of the exercise. We plan to evaluate the additive effect of HIIT and CoQ10, a mitochondrial-targeted therapy, on mitochondrial function and physical performance. Understanding the interplay among CoQ10, exercise, and mitochondrial function will identify novel mechanisms to improve the efficiency of exercise. This will also serve to prevent frailty, sarcopenia, and muscle dysfunction in patients with ESRD.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- First submitted
- 13 Jun 2022
- Start date
- 1 Jun 2023
- Primary completion date
- 20 Jun 2027
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Chronic kidney disease
- NCT number
- NCT05422534
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 156
- From 1 Jun 2023 to the primary completion date, 20 Jun 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of functional transplant less than 6 months prior to study
- Use of immunosuppressive drugs within 1 month prior to study
- Acute infectious disease within 1 month prior to study
- Anticipated live donor kidney transplant
Other illness
- Active connective tissue disease
- AIDS (HIV seropositivity is not an exclusion criterion)
- Acute myocardial infarction or cerebrovascular event within 3 months
- Prolonged ongoing (greater than 20 minutes) angina at rest
- Angina at rest with transient ST changes greater than 0.05 mV on ECG
- Elevated cardiac enzymes (e.g., troponin Tor I greater than 0.1mg/ml)
- Advanced liver disease, with a modified Child-Turcotte-Pugh score equal or greater than 10.
- Active malignancy excluding basal cell carcinoma of the skin
- History of poor adherence to hemodialysis or medical regimen
- Subjects with cardiac pacemaker, artificial heart valve, any metallic implant, permanent tattoo, or any retained foreign metallic bodies.
- Contraindication for exercise such as electrolyte abnormalities, uncontrolled arrhythmias, or pulmonary congestion.
Lab values
- Ejection fraction less than 30%
- Pre-dialysis potassium repeatedly higher than 5.5 mmol/L (confirmed on a repeated blood draw)
Other
- Body mass index \> 35 mg/kg2
- Uncontrolled blood pressure
- New or worsening mitral regurgitation murmur
- Hypotension, bradycardia, or tachycardia
- Sustained ventricular tachycardia on ECG
- Gastrointestinal dysfunction requiring parental nutrition
- Inability to provide consent
- Inability to perform exercise
Who the study is looking for
- Subjects age 18 to 75 years
- On thrice-weekly chronic hemodialysis for at least 6 months (only applicable for patients with ESRD on maintenance hemodialysis).
- Clinically stable, adequately dialyzed (single-pool Kt/V \>1.2) thrice weekly, for at least 3 consecutive months prior to the study (only applicable for patients with ESRD on maintenance hemodialysis)
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center-GCRC Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
| University of California Davis Health Coordinator of this site? Confirm its status | Sacramento | United States | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.